-
1
-
-
84859854912
-
A clinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia
-
Gerber JM, Smith BD, Ngwang B, et al. A clinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia. Blood. 2012;119(15):3571-3577.
-
(2012)
Blood
, vol.119
, Issue.15
, pp. 3571-3577
-
-
Gerber, J.M.1
Smith, B.D.2
Ngwang, B.3
-
2
-
-
36349004183
-
Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity
-
DOI 10.3324/haematol.11366
-
Christ O, Lucke K, Imren S, et al. Improved purification of hematopoietic stem cells base on their elevated aldehyde dehydrogenase activity. Haematologica. 2007;92(9):1165-1172. (Pubitemid 350144173)
-
(2007)
Haematologica
, vol.92
, Issue.9
, pp. 1165-1172
-
-
Christ, O.1
Lucke, K.2
Imren, S.3
Leung, K.4
Hamilton, M.5
Eaves, A.6
Smith, C.7
Eaves, C.8
-
3
-
-
34548132781
-
The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells
-
DOI 10.1016/j.exphem.2007.06.002, PII S0301472X07003530
-
Pearce DJ, Bonnet D. The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells. Exp Hematol. 2007;35(9):1437-1446. (Pubitemid 47302593)
-
(2007)
Experimental Hematology
, vol.35
, Issue.9
, pp. 1437-1446
-
-
Pearce, D.J.1
Bonnet, D.2
-
4
-
-
34250732230
-
Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential
-
Cheung AM, Wan TS, Leung JC, et al. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia. 2007;21(7):1423- 1430.
-
(2007)
Leukemia
, vol.21
, Issue.7
, pp. 1423-1430
-
-
Cheung, A.M.1
Wan, T.S.2
Leung, J.C.3
-
5
-
-
79952202415
-
Characterization of chronic myeloid leukemia stem cells
-
Gerber JM, Qin L, Kowalski J, et al. Characterization of chronic myeloid leukemia stem cells.AmJ Hematol. 2011; 86(1):31-37.
-
(2011)
AmJ Hematol
, vol.86
, Issue.1
, pp. 31-37
-
-
Gerber, J.M.1
Qin, L.2
Kowalski, J.3
-
6
-
-
35848955428
-
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
-
DOI 10.1016/j.stem.2007.08.014, PII S1934590907001336
-
Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555-567. (Pubitemid 350056407)
-
(2007)
Cell Stem Cell
, vol.1
, Issue.5
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
Monville, F.4
Dutcher, J.5
Brown, M.6
Jacquemier, J.7
Viens, P.8
Kleer, C.G.9
Liu, S.10
Schott, A.11
Hayes, D.12
Birnbaum, D.13
Wicha, M.S.14
Dontu, G.15
-
7
-
-
65949112714
-
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis
-
Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009;69(8): 3382-3389.
-
(2009)
Cancer Res
, vol.69
, Issue.8
, pp. 3382-3389
-
-
Huang, E.H.1
Hynes, M.J.2
Zhang, T.3
-
8
-
-
79957917044
-
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival
-
Silva IA, Bai S, McLean K, et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res. 2011;71(11):3991-4001.
-
(2011)
Cancer Res
, vol.71
, Issue.11
, pp. 3991-4001
-
-
Silva, I.A.1
Bai, S.2
McLean, K.3
-
9
-
-
84859845423
-
The leukemic stem cell in polycythemia vera and primary myelofibrosis is distinct from the initiating JAK2 V617F-positive hematopoietic stem cell
-
abstract. Abstract 613
-
Gerber JM, Ngwang B, Zhang H, et al. The leukemic stem cell in polycythemia vera and primary myelofibrosis is distinct from the initiating JAK2 V617F-positive hematopoietic stem cell [abstract]. Blood (ASH Annual Meeting Abstracts). 2011;118: Abstract 613.
-
(2011)
Blood (ASH Annual Meeting Abstracts)
, vol.118
-
-
Gerber, J.M.1
Ngwang, B.2
Zhang, H.3
|